Red Light Holland appoints a new Chief Financial Officer, David Ascott.
Red Light Holland appoints a new Chief Financial Officer, David Ascott.
MINDCURE announces an LOI with Awaken Life Sciences for the deployment of MINDCURE's iSTRYM digital therapeutics platform in Awaken's addiction treatment clinics.
MINDCURE announces its Q1 fiscal 2022 results, including initial release of its iSTRYM platform. Cash and equivalents of CAD$15.6 million as of August 31, 2021.
The rapidly expanding networks of psychedelics-based treatment clinics is a horse race where EVERYONE is a winner.
MindMed announces a new R&D initiative focused on an MDMA derivative, and aimed at treating social anxiety.
Cybin receives IND authorization from the FDA to study ketamine's psychedelic effect on the cerebral cortex.
Levitee Labs announces new credit facility for up to CAD$12 million to finance expansion of its clinics network.
Psychedelic drugs are all over the news. Not just general news but also business media. Big news. Big Business.
The UK drug regulator (MHRS) has granted Small Pharma Fast-Track Designation with respect to SPL026 for Major Depressive Disorder (MDD).
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now